Sadar
Marianne D. Sadar, West Vancouver CA
Patent application number | Description | Published |
---|---|---|
20110230539 | Small Molecule Inhibitors of N-Terminus Activation of the Androgen Receptor - Compounds having a structure of Formula (A) are provided. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are provided. Uses of compounds having a structure of Formula (F) for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. | 09-22-2011 |
20110230556 | Diglycidic Ether Derivative Therapeutics and Methods for Their Use - This invention provides compound having a structure of Formula I or Formula II. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. | 09-22-2011 |
20130109758 | BISPHENOL DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE | 05-02-2013 |
20130131167 | BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS - This invention provides bisphenol derivatives having a structure of formula 1. Said compounds are modulators of the androgen receptor activity and are useful in the treatment of various diseases, including prostate cancer, breast cancer, ovarian cancer, endometrial cancer, acne, ovarian cysts, polycystic ovarian disease, age-related macular degeneration, precocious puberty, hirsutism and hair loss. | 05-23-2013 |
20130245129 | DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE - This invention provides compound having a structure of Formula I or Formula II | 09-19-2013 |
Marianne D. Sadar, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20140335080 | ESTER DERIVATIVES OF ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE - Compounds having a structure of Structure I: | 11-13-2014 |
Marianne Dorothy Sadar, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20130045204 | FLUORINATED BISPHENOL ETHER COMPOUNDS AND METHODS FOR THEIR USE - Compounds having a structure of Formula I: | 02-21-2013 |
20130336962 | AZIRIDINE BISPHENOL ETHERS AND RELATED COMPOUNDS AND METHODS FOR THEIR USE - Compounds having a structure of Formula I: | 12-19-2013 |
Marianne Dorothy Sadar, West Vancouver CA
Patent application number | Description | Published |
---|---|---|
20140248263 | BISPHENOL COMPOUNDS AND METHODS FOR THEIR USE - Compounds having a structure of Formula I: wherein G, a, Q, L | 09-04-2014 |
20150125389 | HALOGENATED COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE - Compounds having a structure of Formula I: | 05-07-2015 |
Marianne Dorthy Sadar, West Vancouver CA
Patent application number | Description | Published |
---|---|---|
20100248290 | METHODS FOR DETECTING LUNG CANCER AND MONITORING TREATMENT RESPONSE - A method is described for detecting lung cancer comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject at risk for developing lung cancer. Further, a method is described for predicting risk of developing lung cancer in a subject comprising detecting an elevated level of a CTAP III-related biomarker in a biological sample from a subject. Additionally, a method of monitoring the success of lung cancer treatment with curative intent is described comprising detecting levels of a CTAP III-related biomarker in a biological sample from a subject undergoing treatment for lung cancer for comparison with the a previous level obtained from the subject. Multivariate analysis may be incorporated into these methods, evaluating such clinical, or demographic risk factors as age, sex, smoking history, smoking status, smoking family history, education level, COPD, socio-economic status, body mass index and lung function. Kits for conducting such methods are described. | 09-30-2010 |
Michael Sadar, Fort Collins, CO US
Patent application number | Description | Published |
---|---|---|
20150192556 | CONTINUOUS TURBIDIMETRIC TOTAL IRON MONITORING - An embodiment provides a method for determining total iron content in real time in a high purity water system including the steps of: assessing total iron content in each of a plurality of water samples having differing total iron content values; measuring, with a high-intensity turbidimeter, the turbidity values associated with each of the plurality of water samples; identifying a linear relationship between total iron content and turbidity of the plurality of samples; providing a high-intensity turbidimeter positioned in a water conduit of the high purity water system which is responsive to the turbidity of the water system; measuring the turbidity value of the water in real time, with the high-intensity turbidimeter, to generate a continuous data stream representative of the turbidity value; providing a processor programmed with the linear relationship identified between total iron content and turbidity of the plurality of samples; and calculating total iron content of the water in real time by transforming the measured turbidity values of the water using the linear relationship identified between total iron content and turbidity of the plurality of samples by use of the processor. Other embodiments are described. | 07-09-2015 |